Overview

Cerebras Systems specializes in accelerating artificial intelligence (AI) through its CS-2 system, which is the fastest AI accelerator available. This system replaces traditional clusters of graphics processing units (GPUs) used in AI computations, simplifying the process by eliminating the need for complex parallel programming and cluster management. Cerebras serves a variety of clients, including major pharmaceutical companies and government research labs, providing them with faster results for critical applications like cancer drug response predictions. The company operates in the high-performance computing and AI markets, generating revenue by selling its CS-2 systems along with associated software and cloud services. Cerebras aims to enhance the efficiency of AI research and development, enabling clients to achieve quicker results and lower costs.

Simplify's Take

What believers are saying

• Growing AI model efficiency demand aligns with Cerebras' energy-efficient accelerators.
• AI democratization increases need for user-friendly systems like Cerebras' CS-2.
• Pharmaceutical industry's push for faster drug discovery boosts demand for Cerebras' technology.

What critics are saying

• Competition from NVIDIA and Graphcore could impact Cerebras' market share.
• Rapid AI model evolution may necessitate frequent hardware updates, increasing R&D costs.
• Supply chain vulnerabilities could delay production of Cerebras' hardware.

What makes Cerebras unique

• Cerebras' Wafer-Scale Engine is the largest chip ever built for AI.
• The CS-2 system replaces traditional GPU clusters, simplifying AI computations.
• Cerebras serves diverse industries, including pharmaceuticals and government research labs.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$720M

Above

Industry Average

Funded Over

6 Rounds

Notable Investors:

Coatue ManagementBenchmarkSequoia CapitalSV Angel

Notable Investors:

Coatue ManagementBenchmarkSequoia CapitalSV Angel

$250,000,000

Series F

Nov 2021

Series F funding comparison data is currently unavailable. We're working to provide this information soon!

Series F Funding Comparison

Coming Soon

View all funding stages